期刊文献+

Lewis y抗原及α1,2-岩藻糖转移酶基因在卵巢癌细胞系中的表达

Expressions of Lewis y Antigen and α1,2-fucose Transferase Gene in Ovarian Cancer Cell Line
下载PDF
导出
摘要 目的探讨卵巢癌细胞系中Lewisy抗原及α1,2-岩藻糖转移酶(α1,2-FT)基因FUT1表达变化对卵巢癌细胞增殖、耐药和转移的影响。方法采用免疫细胞化学法、免疫细胞荧光法测定α1,2-FT基因FUT1转染前后的人卵巢癌细胞系RMG-I和RMG-I-H、人卵巢癌高转移细胞系HO8910PM及亲本细胞系HO8910、人卵巢癌耐药细胞系COC1/DDP及亲本细胞系COC1中Lewisy抗原的表达。利用RT-PCR法及real-time PCR法检测上述6种细胞中FUT1基因表达的变化。结果经免疫化学方法和免疫细胞荧光法分析,在RMG-I-H、HO8910PM及COC1/DDP细胞系中Lewisy表达强度分别为(53.90±4.33),(37.31±0.19)和(28.52±1.45),与相应的亲本细胞系RMG-I(32.18±0.64)、HO8910(14.96±0.61)及COC1(19.26±0.83)比较均明显升高(P均<0.05)。与RMG-I相比,RMG-I-H中的FUT1基因表达上调3.07倍,与HO8910相比,HO8910PM中的FUT1基因表达上调2.13倍,与COC1相比,COC1/DDP中的α1,2-FT基因表达上调2.42倍(P均<0.05)。结论人卵巢癌细胞表面Lewisy抗原与卵巢癌细胞的增殖、耐药及转移等生物学行为密切相关。 Objective To study the expressions of Lewis y antigen and α1,2-fucose transferase(α1,2-fucosyltransferases,α1,2-FT) gene FUT1 in ovarian cancer cell lines and their influences on proliferation,drug resistance and metastasis of ovarian cancer cells.Methods The immuocytochemical method and immunocyto-fluorescence methold were used to detect the expression of Lewis y antigen in RMG-I-H and RMG-I,highly metastatic human ovarian cancer cell line HO8910PM and the parental cell line HO8910,drug-resistant human ovarian cancer cell line COC1/DDP and the parental cell line COC1,which were transfected by α1,2-FT gene(FUT1).Real-time PCR and RT-PCR were used to determine the changes of α1,2-FT expression in these six cell lines.Results Results of the immunochemistry and immunofluorescence analysis showed that the expression intensities of Lewis y in RMG-I-H(53.90±4.33),HO8910PM(37.31±0.19),COC1/DDP(28.52±1.45)were higher than the corresponding parental cell lines RMG-I(32.18±0.64),HO8910(14.96±0.61),COC1(19.26±0.83)(P 0.05).The mRNA expressions of α1,2-fucosyltransferases in RMG-I-H,HO8910 PM and COC1/DDP were higher than the corresponding cell lines RMG-I,HO8910 and COC1(P 0.05).Conclusion Lewis y antigen on human ovarian cancer cell surface is closely related to the proliferation,drug resistance and metastasis of ovarian cancer cells.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2011年第4期289-292,296,共5页 Journal of China Medical University
基金 国家自然科学基金资助项目(30170980 30571958 30872757 81072118) 教育部博士点基金资助项目(20070159023) 辽宁省教育厅重点实验室项目(2008S247) 盛京自由研究者计划(200807) 沈阳市科委基金资助项目(F10-14-9-9-52)
关键词 LEWIS y抗原 α1 2-岩藻糖转移酶 FUT1 卵巢肿瘤 Lewis y antigen α1 2-fucose transferase FUT1 ovarian cancer
  • 相关文献

参考文献5

二级参考文献68

  • 1林蓓,齐藤真木子,岩森正男.小鼠α1,2岩藻糖基转移酶基因的克隆及表达[J].实验生物学报,2005,38(6):536-544. 被引量:1
  • 2刘涛,孔垂泽,毕建斌,刘戈飞.蛋白激酶C抑制剂逆转肾癌多药耐药机制的探讨[J].中华肿瘤杂志,2006,28(2):92-95. 被引量:9
  • 3林蓓,齐藤真木子,岩森正男.小鼠3种α1,2岩藻糖转移酶的底物特异性[J].中国医学科学院学报,2005,27(6):761-766. 被引量:1
  • 4张甦琳,孔维佳.喉癌体外药物敏感实验对化疗指导性的研究[J].临床耳鼻咽喉科杂志,2006,20(15):711-713. 被引量:3
  • 5Liu F, Qi HL & Chen HL, Regulation of differentiationand prolifertion-inducers on Lewis antigens, alpha-fucosyhransferase and metastatic potential in hepatocarcinoma cells. Br J Cancer, 2001 ; 84(11) : 1 556-1 563.
  • 6Inufusa H, Adachi T, Kiyokawa T, Nakatani Y, Wakano T, Nakamura M, Okuno K, Shiozaki H, Yamamoto S, Suzuki M, Ando O, Kurimoto M, Miyake M & Yasutomi M, Ley glycolipid-recognizing monoclonal antibody inhibits procoagulant activity and metastasis of human adenocarcinoma. Int J Oncol, 2001, 19(5) : 941-946.
  • 7Scott AM, Geleick D, Rubira M, Clarke K, Nice EC, Smyth FE, Stockert E, Richards EC, Carr FL, Harris WJ, Armour KL, Rood J, Kypridis A, Kronina V, Murphy R, Lee Fr, Liu Z, Kitamura K, Rittter G, Laughton K, Hoffman E, Burgess AW & Old I J, Construction, production, and characterization of humanized anti-Lewis y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors. Cancer Research, 2000, 60(15): 3 254-3 261.
  • 8Sabbatini PJ, Kudryashov V, Ragupathi G, Danishefsky S J, Livingston PO, Bornmann W, spassova M, Zatorski A, Spriggs D, Aghajanian C, Soignet S, Pevton M, O'Flaherty CC, Curtin J & Lloyd KO, Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial. Int J Cancer, 2000, 87(1): 79-85.
  • 9Halloran MM, Carley WW, Polverini PJ, Haskell C J, Phan S, Anderson B J, Woods JM, Campbell PL, Volin MV, Backer AE & Koch AE, Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. J Immunol, 2000, 164(9): 4 868-4 877.
  • 10Basu A, Murthy U, Rodeck U, Herlyn M, Mattes L & Das M, Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas. CancerRes, 1987, 47(10): 2 531-2 536.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部